Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
Allergan Plc on Tuesday reported better-than-expected quarterly profit on robust demand for Botox, boosted its earnings forecast and announced positive data on one of the two migraine treatments it is developing.
NEW YORK The U.S. government on Thursday proposed an increase of 1.84 percent on average in its 2019 payments to the health insurers that manage Medicare Advantage insurance plans for more than 20 million elderly or disabled people.
NEW YORK Amazon.com Inc , Berkshire Hathaway Inc and JPMorgan Chase & Co said on Tuesday they will form a company to cut health costs for hundreds of thousands of their employees, setting up a major challenge to an inefficient U.S. healthcare system. | Video
WASHINGTON/NEW YORK U.S. health officials said on Friday they were revoking legal guidance issued by the Obama administration that had sought to discourage states from trying to defund organizations that provide abortion services, such as Planned Parenthood.
UnitedHealth Group Inc on Tuesday raised its outlook for 2018 earnings per share by more than 16 percent due to the U.S. corporate tax cut and said it will speed up technology investments that aim to cut customer costs.
SAN FRANCISCO Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.
SAN FRANCISCO, Jan 12 Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.
SAN FRANCISCO The Trump administration's tax overhaul should accelerate major acquisitions by drugmakers in 2018 after a slow year for deals in 2017, according to senior executives from some of the largest pharmaceutical manufacturers.
NEW YORK Slightly fewer Americans have enrolled for insurance through the federal Obamacare marketplace compared to a year ago, the government said on Thursday, but the number was higher than expected in light of steps taken by President Donald Trump and Congress to undermine the 2010 law. | Video
NEW YORK CVS Corp’s proposed purchase of Aetna Inc will affect decision-making by a majority of large and mid-size U.S. corporations on employee health benefits, a survey by benefits consultant Aon Plc found.
- Gold: PRECIOUS-Gold falls for third session ahead of big U.S. debt auction
- Oil Report: CORRECTED-UPDATE 1-Romania says its natural gas output set to double by 2025
- British Pound Report: UPDATE 1-Sterling bounces on media report EU parliament for Brexit flexibility
- US Dollar Report: FOREX-Dollar extends recovery as traders eye Treasury auction